Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Regorafenib Use Among Advanced Gastrointestinal Stromal Tumors

NCT06321055 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06321055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06321055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Regorafenib Use Among Advanced Gastrointestinal Stromal Tumors
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
March 1, 2024
Completion date
May 1, 2024
Enrollment
136 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastrointestinal stromal tumor